US equities |
SPCX $166.85 ▲+4.96% NVDA $236.16 ▲+0.94% MU $1,062.72 ▼-1.13% TSLA $377.64 ▲+1.90% MSFT $524.56 ▲+1.36% SNDK $1,705.18 ▼-0.86% INTC $117.16 ▼-1.82% META $742.58 ▲+1.99%
FinancialContent

Polyrizon Ltd. - Ordinary Shares (NQ:PLRZ)

9.550 -0.060 (-0.62%)
Delayed Quote Updated: 12:05 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Polyrizon Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Top stock movements in today's session. ↗
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
These stocks are gapping in today's session ↗
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. 
Via Chartmill
News headline image
Polyrizon Ltd. Announces $17.0 Million Private Placement
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon Structures Clinical Strategy for its Allergy Blocker Ahead of FDA Pre-Submission Meeting
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Top movers in Tuesday's after hours session ↗
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Is Development-Stage Biotech Company Polyrizon Stock Surging Today? ↗
Polyrizon shares rise after disclosing the publication of a national phase patent application for nasal protection and drug delivery technologies. 
Via Benzinga
Topics Intellectual Property
News headline image
Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
From Polyrizon Ltd.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Crude Oil Gains Over 1%, General Mills Shares Fall ↗
 
Via Benzinga
News headline image
What's Going On With Polyrizon Shares Wednesday? ↗
Polyrizon shares are moving higher after the company announced it secured a manufacturing agreement with Eurofins CDMO Amatsiaquitaine. 
Via Benzinga
News headline image
Dow Surges 150 Points, US Current Account Deficit Widens In Q3 ↗
 
Via Benzinga
Topics Stocks
< Previous 1 2 3 4 5 6 7 8 Next >